{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T02:38:48Z","timestamp":1789958328636,"version":"4.0.1"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T00:00:00Z","timestamp":1638230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Renal cell carcinoma (RCC) associated with Xp11.2 translocation\/<jats:italic>TFE3<\/jats:italic> gene fusion is a rare and new subtype of RCC and was classified by the WHO in 2004. Since then, multiple 5\u2032 fusion partners for <jats:italic>TFE3<\/jats:italic> have been reported; however, the impact of individual fusion variant on specific clinicopathologic features of Xp11.2 RCCs has not been well defined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Four Xp11.2 translocation RCCs were identified by morphological, immunostaining, and fluorescence <jats:italic>in situ<\/jats:italic> hybridization (FISH) assays from 200 patients who attended Guangdong General Hospital between January 2017 and January 2020. All these four cases were further analyzed by RNA sequencing to explore their <jats:italic>TFE3<\/jats:italic> gene fusion partners. The clinicopathologic features, including clinical manifestations, pathological findings, treatment strategies, clinical outcomes, and follow-up information on Xp11.2 translocation RCCs, were recorded and evaluated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>These four cases affected one male and three females. The median age was 13 years at the time of diagnosis (range = 4\u201320 years). All the examined tumors were unilateral and unifocal. The largest diameter of these tumors ranged from 2.0 to 10.0 cm, and the average was 5.55 cm. Regional lymph node or distant metastasis developed in two patients. Three cases demonstrated known fusions: <jats:italic>ASPCR1<\/jats:italic>\u2013<jats:italic>TFE3<\/jats:italic> (two cases) and <jats:italic>PRCC<\/jats:italic>\u2013<jats:italic>TFE3<\/jats:italic> (one case). However, one case showed an unreported <jats:italic>VCP<\/jats:italic>\u2013<jats:italic>TFE3<\/jats:italic> fusion gene in Xp11.2 translocation RCCs. Immunohistochemistry results revealed tumor cells diffusely positive for <jats:italic>TFE3<\/jats:italic>, but have no consistency in other markers. Moreover, there were different clinical prognoses among the different variant <jats:italic>TFE3<\/jats:italic> rearrangements; RCC patients with <jats:italic>VCP<\/jats:italic>\u2013<jats:italic>TFE3<\/jats:italic> translocation had worse prognosis compared to those with other fusion types. Follow-up were available for all the patients and ranged from 3 to 36 months. Three patients were without evidence of disease progression, while that with <jats:italic>VCP<\/jats:italic>\u2013<jats:italic>TFE3<\/jats:italic> fusion died of the disease 3 months after the diagnosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In conclusion, our data expand the list of <jats:italic>TFE3<\/jats:italic> gene fusion partners and the clinicopathologic features of Xp11.2 RCCs with specific <jats:italic>TFE3<\/jats:italic> gene fusions. We identified a novel <jats:italic>VCP<\/jats:italic>\u2013<jats:italic>TFE3<\/jats:italic> fusion in Xp11.2 translocation RCCs for the first time, which has unique morphology and worse prognosis than those with other variant <jats:italic>TFE3<\/jats:italic> rearrangements. Integration of morphological, immunohistochemical, and molecular methods is often necessary for the precise diagnosis and optimal clinical management of malignant tumors.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2021.784993","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T14:53:22Z","timestamp":1638370402000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Xp11.2 Translocation Renal Cell Carcinoma With TFE3 Rearrangement: Distinct Morphological Features and Prognosis With Different Fusion Partners"],"prefix":"10.3389","volume":"11","author":[{"given":"Yan","family":"Ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingtao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luqiao","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,30]]},"reference":[{"key":"B1","article-title":"Renal Carcinoma Associated With Xp11.2 Translocations\/TFE3 Gene Fusions","volume-title":"Tumors of the Urinary System and Male Genital Organs","author":"Argani","year":"2004"},{"key":"B2","article-title":"MiT Family Translocation Renal Cell Carcinoma","volume-title":"WHO Classification of Tumours of the Urinary System and Male Genital Organs","author":"Argani","year":"2016"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e0185337","DOI":"10.1371\/journal.pone.0185337","article-title":"PRCC-TFE3 Dual-Fusion FISH Assay: A New Method for Identifying PRCC-TFE3 Renal Cell Carcinoma in Paraffin-Embedded Tissue","volume":"12","author":"Lei","year":"2017","journal-title":"PloS One"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318031ffff","article-title":"Xp11 Translocation Renal Cell Carcinoma in Adults: Expanded Clinical, Pathologic, and Genetic Spectrum","volume":"31","author":"Argani","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1994.tb06696.x","article-title":"PU.1 and an HLH Family Member Contribute to the Myeloid-Specific Transcription of the Fc Gamma RIIIA Promoter","volume":"13","author":"Feinman","year":"1994","journal-title":"EMBO J"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-018-0051-5","article-title":"RNA Sequencing of Xp11 Translocation-Associated Cancers Reveals Novel Gene Fusions and Distinctive Clinicopathologic Correlations","volume":"31","author":"Wang","year":"2018","journal-title":"Mod Pathol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.22798","article-title":"Gene Fusion Analysis in Renal Cell Carcinoma by FusionPlex RNA-Sequencing and Correlations of Molecular Findings With Y, Mukai H, Clinicopathological Features","volume":"59","author":"Tretiakova","year":"2020","journal-title":"Genes Chromosomes Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.22830","article-title":"A Renal Cell Carcinoma With EWSR1-TFE3 Fusion Gene","volume":"59","author":"Lang","year":"2020","journal-title":"Genes Chromosomes Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cll.2005.01.008","article-title":"Translocation Carcinomas of the Kidney","volume":"25","author":"Argani","year":"2005","journal-title":"Clin Lab Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200306000-00005","article-title":"Aberrant Nuclear Immunoreactivity for TFE3 in Neoplasms With TFE3 Gene Fusions: A Sensitive and Specific Immunohistochemical Assay","volume":"27","author":"Argani","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2008.03151","article-title":"Renal Cell Carcinoma in Children and Young Adults: Analysis of Clinicopathological, Immunohistochemical and Molecular Characteristics With an Emphasis on the Spectrum of Xp11.2 Translocation-Associated and Unusual Clear Cell Subtypes","volume":"53","author":"Wu","year":"2008","journal-title":"Histopathology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-1183","article-title":"Adult Xp11 Translocation Renal Cell Carcinoma Diagnosed by Cytogenetics and Immunohistochemistry","volume":"15","author":"Komai","year":"2009","journal-title":"Clin Cancer Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181609914","article-title":"Renal Translocation Carcinomas: Clinicopathologic, Immunohistochemical, and Gene Expression Profiling Analysis of 31 Cases With a Review of the Literature","volume":"32","author":"Camparo","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-019-00792-0","article-title":"Clinicopathological Findings on 28 Cases With XP11.2 Renal Cell Carcinoma","volume":"26","author":"Kuthi","year":"2020","journal-title":"Pathol Oncol Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000631","article-title":"TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers","volume":"40","author":"Argani","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206686","article-title":"A Novel CLTC-TFE3 Gene Fusion in Pediatric Renal Adenocarcinoma With T(X; 17) (P11.2; Q23)","volume":"22","author":"Argani","year":"2003","journal-title":"Oncogene"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.14670\/HH-18-159","article-title":"MiT Family Translocation Renal Cell Carcinomas: A 15th Anniversary Update","volume":"35","author":"Gandhi","year":"2020","journal-title":"Histol Histopathol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2016.204","article-title":"Xp11.2 Translocation Renal Cell Carcinoma With NONO-TFE3 Gene Fusion: Morphology, Prognosis, and Potential Pitfall in Detecting TFE3 Gene Rearrangement","volume":"30","author":"Xia","year":"2017","journal-title":"Mod Pathol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1159\/000134127","article-title":"Mapping the X Chromosome Breakpoint in Two Papillary Renal Cell Carcinoma Cell Lines With a T(X;1)(p11.2;q21.2) and the First Report of a Female Case","volume":"71","author":"Shipley","year":"1995","journal-title":"Cytogenet Cell Genet"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20010515)91:10<1956::AID-CNCR1219>3.0.CO;2-F","article-title":"Fusion of a Novel Gene, RCC17, to the TFE3 Gene in T(X;17) (P11.2; Q25.3)-Bearing Papillary Renal Cell Carcinomas","volume":"61","author":"Heimann","year":"2001","journal-title":"Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001541","article-title":"Morphologic and Immunohistochemical Characteristics of Fluorescent in Situ Hybridization Confirmed TFE3-Gene Fusion Associated Renal Cell Carcinoma: A Single Institutional Cohort","volume":"44","author":"Akgul","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)61684-7","article-title":"Primary Renal Neoplasms With the ASPL-TFE3 Gene Fusion of Alveolar Soft Part Sarcoma: A Distinctive Tumor Entity Previously Included Among Renal Cell Carcinomas of Children and Adolescents","volume":"59","author":"Argani","year":"2001","journal-title":"Am J Pathol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31828a69ae","article-title":"Utilization of a TFE3 Break-Apart FISH Assay in a Renal Tumor Consultation Service","volume":"37","author":"Green","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200212000-00003","article-title":"PRCC-TFE3 Renal Carcinomas: Morphologic, Immunohistochemical, Ultrastructural, and Molecular Analysis of an Entity Associated With the T(X;1)(P11.2;q21)","volume":"26","author":"Argani","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000837","article-title":"Xp11 Translocation Renal Cell Carcinomas (RCCs) With RBM10-TFE3 Gene Fusion Demonstrating Melanotic Features and Overlapping Morphology With T (6;11) RCC: Interest and Diagnostic Pitfall in Detecting a Paracentric Inversion of TFE3","volume":"41","author":"Xia","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/5974089","article-title":"A Rare Partner of TFE3 in the Xp11 Translocation Renal Cell Carcinoma: Clinicopathological Analyses and Detection of MED15-TFE3 Fusion","volume":"11","author":"Ye","year":"2019","journal-title":"BioMed Res Int"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-018-0191-7","article-title":"NEAT1-TFE3 and KAT6A-TFE3 Renal Cell Carcinomas, New Members of MiT Family Translocation Renal Cell Carcinoma","volume":"32","author":"Pei","year":"2019","journal-title":"Mod Pathol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1080\/00313020310001619901","article-title":"Distinctive Neoplasms Characterised by Specific Chromosomal Translocations Comprise a Significant Proportion of Pediatric Renal Cell Carcinomas","volume":"35","author":"Argani","year":"2003","journal-title":"Pathology"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-3036","article-title":"Next-Generation Sequencing of Translocation Renal Cell Carcinoma Reveals Novel RNA Splicing Partners and Frequent Mutations of Chromatin-Remodeling Genes","volume":"20","author":"Malouf","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.22261","article-title":"Identification of a Novel PARP14-TFE3 Gene Fusion From 10-Year-Old FFPE Tissue by RNA-Seq","volume":"54","author":"Huang","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/his.13167","article-title":"Incidence, Clinicopathological Features and Fusion Transcript Landscape of Translocation Renal Cell Carcinomas","volume":"70","author":"Classe","year":"2017","journal-title":"Histopathology"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-018-0175-7","article-title":"Diagnosis of Known Sarcoma Fusions and Novel Fusion Partners by Targeted RNA Sequencing With Identification of a Recurrent ACTB-FOSB Fusion in Pseudomyogenic Hemangioendothelioma","volume":"32","author":"Zhu","year":"2019","journal-title":"Mod Pathol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2013.208","article-title":"Clinical Heterogeneity of Xp11 Translocation Renal Cell Carcinoma: Impact of Fusion Subtype, Age, and Stage","volume":"27","author":"Ellis","year":"2014","journal-title":"Mod Pathol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-0723-03","article-title":"Expression Level of Valosin-Containing Protein (P97) Is Associated With Prognosis of Esophageal Carcinoma","volume":"10","author":"Yamamoto","year":"2004","journal-title":"Clin Cancer Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-1576-03","article-title":"Expression of Valosin-Containing Protein in Colorectal Carcinomas as a Predictor for Disease Recurrence and Prognosis","volume":"10","author":"Yamamoto","year":"2004","journal-title":"Clin Cancer Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-03-0191","article-title":"Elevated Expression of Valosin-Containing Protein (P97) Is Associated With Poor Prognosis of Prostate Cancer","volume":"10","author":"Tsujimoto","year":"2004","journal-title":"Clin Cancer Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e29073","DOI":"10.1371\/journal.pone.0029073","article-title":"Critical Role of VCP\/p97 in the Pathogenesis and Progression of Non-Small Cell Lung Carcinoma","volume":"6","author":"Valle","year":"2011","journal-title":"PloS One"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1126\/science.1164368","article-title":"Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses","volume":"26","author":"Jones","year":"2008","journal-title":"Science"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.4103\/0377-4929.120358","article-title":"Inhibiting Valosin-Containing Protein Suppresses Osteosarcoma Cell Metastasis via AKT\/nuclear Factor of Kappa B Signaling Pathway In Vitro","volume":"56","author":"Long","year":"2013","journal-title":"Indian J Pathol Microbiol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/s1074-7613(00)80145-4","article-title":"Synergistic Roles for Pim-1 and C-Myc in STAT3-Mediated Cell Cycle Progression and Antiapoptosis","volume":"11","author":"Shirogane","year":"1999","journal-title":"Immunity"},{"key":"B41","article-title":"Differential Transactivation by Alternative EWS-FLI1 Fusion Proteins Correlates With Clinical Heterogeneity in Ewing's Sarcoma","volume":"59","author":"Lin","year":"1999","journal-title":"Cancer Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64953-X","article-title":"Association of EWS-FLI1 Type 1 Fusion With Lower Proliferative Rate in Ewing's Sarcoma","volume":"156","author":"de Alava","year":"2000","journal-title":"Am J Pathol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.4.1248","article-title":"EWS-FLI1 Fusion Transcript Structure Is an Independent Determinant of Prognosis in Ewing's Sarcoma","volume":"16","author":"de Alava","year":"1998","journal-title":"J Clin Oncol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3760\/cma.j.cn112151-20210421-00308","article-title":"MAML2 Gene Rearrangement, Fusion Patterns and Clinicopathological Characteristics in Primary Pulmonary Mucoepidermoid Carcinoma","volume":"50","author":"Zhang","year":"2021","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"B45","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/PAP.0000000000000291","article-title":"Molecular Pathology of Salivary Gland Neoplasms: Diagnostic, Prognostic, and Predictive Perspective","volume":"28","author":"Toper","year":"2021","journal-title":"Adv Anat Pathol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24532","article-title":"PAX-FOXO1 Fusion Status Drives Unfavorable Outcome for Children With Rhabdomyosarcoma: A Children's Oncology Group Report","volume":"60","author":"Skapek","year":"2013","journal-title":"Pediatr Blood Cancer"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.784993\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T14:53:31Z","timestamp":1638370411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.784993\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,30]]},"references-count":46,"alternative-id":["10.3389\/fonc.2021.784993"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.784993","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,30]]},"article-number":"784993"}}